Skip to main content

ARTICLES BY THIS AUTHOR

  • 6/16/2013

    Canada trails in access to orphan drugs for rare diseases

    TORONTO | Access to orphan drugs – pharmaceuticals developed specifically to treat very rare medical conditions – has been more challenging for Canadians than patients in most other developed countries.
  • 6/13/2013

    GE hybrid imaging scanner approved by Health Canada

    MISSISSAUGA, ONT. | GE Healthcare says it has received a new medical device licence from Health Canada for its Optima NM/CT 640, described as a new performance SPECT/CT system that helps physicians balance low patient radiation dose and performance efficiency with diagnostic image quality.
  • 6/13/2013

    Women go into menopause because men want younger mates, study suggests

    Theories abound as to why women go into menopause, but the latest hypothesis being put forward suggests it may be men—or specifically their preference for younger mates—that has led to women's loss of fertility at a certain age. Researchers at McMaster University believe that over tens of thousands of years, a lack of reproduction among older women has given rise to menopause as an unintended result of evolutionary natural selection.
  • 6/13/2013

    CAPT CORNER—June 2013

    Vancouver PDC a SUCCESS
  • 6/13/2013

    Press Review - June 14, 2013

    Check out our review of recent medical stories in the media - <strong>Top Story: </strong>'Intimate partner violence' not getting enough doctors' attention, new study reveals. Read this and
  • 6/13/2013

    Mind the gap

    CPhA national conference points to change
  • 6/13/2013

    Family points to two doctors in death of young mother

    Aboriginal chiefs from northern Manitoba are calling for an inquest after family members blamed two physicians for the death of a young mother.
  • 6/13/2013

    You’ve come a long way, baby

    CAPT conference speakers encourage techs to take ownership of new role
  • 6/12/2013

    One-stop shop for clinical research

    The innovative HUB program offers the research community a full range of expertise from St. Michael’s Hospital
  • 6/12/2013

    Xtandi: new oral androgen receptor inhibitor for metastatic prostate cancer

    Drug is intended for patients who have undergone medical or surgical castration and who have received docetaxel therapy.